CVS generic competitor to EpiPen, sold at a 6th the price
CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to consumers.
The drugstore chain says it will charge $109.99 for a two-pack of the authorized generic version of Adrenaclick, a lesser-known treatment compared to EpiPen, which can cost more than $600.
[...] patients with no health insurance or plans that make them pay a high deductible before covering care can be exposed to the full price of the drug if they aren't aware of that financial aid or if they don't seek it.